Overview
- The stock fell 23.9% from last Friday through Thursday’s close, including a 14% drop to $30.37 in the latest session, marking six straight days of declines.
- Wolfpack Research alleges IonQ lost funding tied to Pentagon work it says made up about 86% of sales from 2022 to 2024.
- The report also questions the legitimacy of a previously announced $22 million agreement with EPB Chattanooga.
- Wolfpack disclosed a short position in IonQ and urged investors to sell, highlighting its financial incentive for a decline.
- There have been no detailed company updates countering the claims, a law firm announced an inquiry, and the upcoming fourth-quarter 2025 results are seen as the key checkpoint.